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Abstract
Background: Insomnia symptoms are associated with type 2 diabetes incidence but are also associated with a
range of potential time-varying covariates which may confound and/or mediate associations. We aimed to assess
whether cumulative exposure to insomnia symptoms has a causal effect on type 2 diabetes incidence.
Methods: A prospective cohort study in the West of Scotland, following respondents for 20 years from age 36. 996
respondents were free of diabetes at baseline and had valid data from up to four follow-up visits. Type 2 diabetes
was assessed at the final visit by self-report, taking diabetic medication, or blood-test (HbA1c ≥ 6.5% or 48 mmol/
mol). Effects of cumulative insomnia exposure on type 2 diabetes incidence were estimated with traditional
regression and marginal structural models, adjusting for time-dependent confounding (smoking, diet, physical
inactivity, obesity, heavy drinking, psychiatric distress) as well as for gender and baseline occupational class.
Results: Traditional regression yielded an odds ratio (OR) of 1.34 (95% CI: 1.06-1.70) for type 2 diabetes incidence
for each additional survey wave in which insomnia was reported. Marginal structural models adjusted for prior
covariates (assuming concurrently measured covariates were potential mediators), reduced this OR to 1.20 (95% CI:
0.98-1.46), and when concurrent covariates were also included (viewing them as potential confounders) this
dropped further to 1.08 (95% CI: 0.85-1.37).
Conclusions: The association between cumulative experience of insomnia and type 2 diabetes incidence appeared
confounded. Evidence for a residual causal effect depended on assumptions as to whether concurrently measured
covariates were confounders or mediators.
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Background
Insomnia symptoms (defined here as trouble initiating
or maintaining sleep) are associated with risk of type 2
diabetes [1–3]. Insomnia can be effectively treated [4]
and may be a promising avenue for interventions to re-
duce type 2 diabetes incidence, as there are plausible
biological mechanisms linking sleep loss to the develop-
ment of type 2 diabetes via increases in insulin resist-
ance and appetite [5, 6].
However, treatment of insomnia will only be effective
at reducing risk of type 2 diabetes if the relationship be-
tween insomnia symptoms and type 2 diabetes is causal.
Whilst observational studies show associations between
insomnia symptoms and type 2 diabetes incidence [1–3],
these may be confounded by other mechanisms. Indeed,
socioeconomic position (SEP), smoking, heavy drinking,
physical inactivity, poor diet and psychiatric distress are
all associated with increased risk of insomnia symptoms
or short sleep duration as well as type 2 diabetes [7–19].
Psychiatric distress and being overweight/obese may even
have reciprocal relationships with sleeping trouble where
each aggravates the other [6, 19]. This paper aims to assess
whether associations between insomnia symptoms and
type 2 diabetes incidence are likely to be causal by using
marginal structural models (MSMs) to effectively control
for time-varying confounders, and comparing results with
more traditional regression models.
Consider Fig. 1a, where time-varying insomnia symp-
toms are both influenced by, and influence, a set of time-
varying covariates (e.g. smoking, physical inactivity etc),
and both insomnia and these covariates are determinants
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of type 2 diabetes (the subscripts 0 and 1 indicate that
insomnia and the covariates are measured at two succes-
sive time-points). The time-varying covariates may both
confound associations between insomnia and type 2 dia-
betes (e.g. insomnia1 to type 2 diabetes is confounded by
covariates0 and covariates1), but may also mediate causal
effects of insomnia on type 2 diabetes (i.e. insomnia0 to
covariates1 to type 2 diabetes). Mediation might occur for
example if poor sleep increased appetite leading to poor
diet/obesity and then to type 2 diabetes.
Assuming no further unmeasured confounding of the
relationship between insomnia and type 2 diabetes,
traditional regression approaches which condition on
time-varying covariates will give biased estimates of the
causal effect of insomnia. There are two reasons for
this. First, conditioning on time-varying covariates sim-
ultaneously removes both their confounding influence
and their mediated effect [20]. Confounding influences
should be removed from effect estimates but mediated
effects should not. Second, if some unmeasured factor
confounds the association between the time-varying co-
variates and type 2 diabetes (as in Fig. 1b), conditioning
on the time-varying covariates induces an association be-
tween that unmeasured factor and insomnia (represented
by the dashed line), opening up a path from insomnia to
type 2 diabetes which does not run via the time-varying
covariates and is not causal, thus biasing estimates of in-
somnia’s effect. This is known as collider bias [21]. Both
problems are still issues where insomnia and covariates
are only measured at a single time-point (e.g. if only in-
somnia1 and covariates1 were observed) as the relevant
mediating pathways may still be present, just unobserved
(indeed, in this instance covariates0 could be the unmeas-
ured confounder introducing collider bias).
MSMs avoid both of these problems by using the
covariates to calculate analysis weights rather than by
conditioning on them [20, 22]. The weights create a
pseudo-population where at each time point those with
and without insomnia will have similar covariate histories,
but might differ systematically in covariates measured
after that time point. This allows for mediation via covari-
ates and does not induce the dashed association which
causes collider bias in Fig. 1b. This paper compares
traditional regression analysis with MSMs to explore the
impact of effectively adjusting for time-varying covariates
on our understanding of the causal relationship between
insomnia and diabetes.
We additionally explore whether conclusions are ro-
bust to different causal assumptions. Where insomnia
symptoms and time-varying covariates are measured
concurrently, Fig. 1a and b show the conservative as-
sumption that causation runs from the covariates to in-
somnia. Under this assumption concurrently measured
covariates should be included when calculating weights
for MSMs. An alternative, less conservative, assumption
is depicted in Fig. 1c. In this case, concurrently mea-
sured covariates are viewed as caused by insomnia, and
hence as mediators of insomnia’s effect. This means
concurrent covariates should not be included when
calculating weights, while earlier measurements of
covariates are still potential confounders and should be
included. We repeat analyses with and without concur-
rent covariates included in the weighting to see if con-
clusions are sensitive to these assumptions.
Methods
Sample
Data are from the Twenty-07 Study [23] which followed
people in three age cohorts – born around 1932, 1952,
and 1972 - for 20 years. It has two samples: the regional
sample, a two-stage stratified random sample of people
living in an area of the West of Scotland centred on
Glasgow (previously known as the Central Clydeside
Conurbation), and the localities sample of people from
two areas of the city of Glasgow. Baseline interviews
were conducted in 1987/88 and there have been four
Fig. 1 Causal diagrams of time-varying confounding a time-varying con-
founding with covariates influencing concurrent insomnia; b collider bias
that can occur when conditioning on time-varying covariates; c time-
varying confounding with covariates influenced by concurrent insomnia
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waves of follow-up (1990/2; 1995/7; 2000/4; 2007/8).
This paper focuses on the 1950s birth cohort who aged
from approximately 36 to 57 years during the study
period, covering the age range in which type 2 diabetes
is most likely to develop. This cohort had a baseline
sample size of 1444 (the response rate was 88.9%), which
has been shown to be representative of the general
population of the sampled area [24]. The analysis sample
for this paper was a sub-set of respondents from the
1950s cohort who participated in both the baseline and
the final interview and were free of diabetes at baseline
(n = 996; 73% of the living baseline sample; n = 3 ex-
cluded for baseline diabetes; n = 445 did not participate
at the final interview). Implications of sample attrition
are discussed below.
Measures
Type 2 diabetes was indicated by either self-reporting
of the condition, self-reporting of diabetic medication
(medications coded 6.1 in the British National Formu-
lary) [25], or blood-test results indicating HbA1c ≥ 6.5%
(48 mmol/mol). Respondents without valid blood re-
sults (n = 125) were still included and coded based on
self-reported conditions and medications. Overall 68
respondents were coded as developing type 2 diabetes
(28 by self-reported conditions or medications only, 10
by blood test results only, and 30 by both self-report
and blood test). Baseline exclusions of existing cases
were made on the basis of self-reported conditions/
medications only as blood tests were not available until
the final interview. A sensitivity analysis used a less
conservative cut off of HbA1c ≥ 6% (42 mmol/mol;
identifying a further 50 potential cases).
Gender was coded 0 for males and 1 for females. SEP
was measured as baseline household occupational class,
coded according to the Registrar General’s 1980 classifi-
cation [26], using the higher status occupation from
couple households, with a binary indicator for manual vs
non-manual occupations. This well-validated measure
represents the material resources available to the house-
hold as well as their social standing [27].
In the first three interviews respondents were asked
“How often do you have trouble getting to sleep?” and
“How often are you bothered by waking earlier than
you would like to, or by waking up in the middle of the
night?” Both questions had six available responses
ranging from never to every day. In the fourth and fifth
interviews, respondents were asked, as part of the
Pittsburgh Sleep Quality Index [28], “During the past
month how often have you had trouble sleeping be-
cause you cannot get to sleep within 30 minutes?” and
“During the past month how often have you had
trouble sleeping because you wake up in the middle of
the night or early morning?” Both questions had four
response categories ranging from not during the past
month to 3 or more times a week. Responses indicating
at least weekly trouble initiating or maintaining sleep
were coded as insomnia symptoms (a sensitivity ana-
lysis where insomnia was defined as weekly trouble
with both initiation and maintenance of sleep produced
similar results).
Current smoking, physical activity, past week alcohol
consumption and fruit and vegetable consumption (as
an indication of diet) were self-reported at each wave.
For consistency across all confounders, they were
coded as binary indicators. Respondents who reported
any current smoking were coded as smokers. Physical
inactivity was coded as not taking part in any weekly
activity “lasting more than 20 min” that made them
“sweat or out of breath”. Heavy drinking, based on past
week alcohol consumption, was coded as >14 units for
women and >21 units for men [29]. Less than daily con-
sumption of fruit and vegetables was coded as poor diet.
Height (m) and weight (kg) were recorded by trained
nurses and used to calculate body mass index (BMI) at
each wave (weight/height2). A BMI of 30+ was coded as
obese (similar results were obtained using a 25+ threshold
to indicate being overweight). Psychiatric distress was in-
dicated at each interview by scores of 2 or more on the
12-item General Health Questionnaire (GHQ; scored
using caseness method) [30], a well-validated scale for
assessing psychiatric morbidity. Since one of the items on
this scale refers to losing sleep over worry, this item was
removed from the scoring, though analyses with the full
scale produced similar results.
Analysis
Analyses were conducted in Mplus 7 [31] and SPSS v21.
Considering attrition, the analysis sample was weighted to
the living baseline sample throughout [32]. Within the ana-
lysis sample, rates of missing information across the five
waves for insomnia symptoms and most covariates, except
GHQ, were in the range 7.8-13.8% (see Table 1). There was
a particularly high rate of missing information for psychi-
atric distress (23.9%) as a questionnaire error at wave 3
meant the GHQ could not be scored correctly for respon-
dents in the regional sample (though this kind of missing-
ness can be assumed to be random). Multiple imputation
(25 datasets) was used throughout in addition to attrition
weighting [33, 34]. Imputations employed an unrestricted
two-level model of the analysis variables (repeated mea-
surements nested within persons; gender, occupational
class, type 2 diabetes and attrition weights were included at
the person level; insomnia symptoms, smoking, physical in-
activity, poor diet, obesity, heavy drinking and psychiatric
distress were included at the repeated measurement level).
Multiple imputation performs efficiently for dealing with
missing data in marginal structural models [35].
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After attrition-weighting and imputation, we performed
a traditional logistic regression of type 2 diabetes on a
measure of cumulative insomnia exposure (i.e. the total
number of study waves in which insomnia symptoms were
reported, not necessarily consecutively; range 0-5), condi-
tioning on all covariates (including measures from all
waves). ORs associated with this cumulative measure of
insomnia exposure represent the additional risk for type 2
diabetes associated with each additional wave where in-
somnia symptoms were reported, approximating a dose-
response relationship. We then compared results from
this traditional analysis with estimates of the effect of cu-
mulative insomnia exposure on type 2 diabetes from
MSMs, i.e. using weights to adjust for covariates, rather
than conditioning on them. For both methods, p-values
<0.05 were considered significant.
Weights for MSMs were calculated within each im-
puted data set by estimating two sets of probabilities for
observed exposure levels (numerator and denominator
probabilities). Probabilities from each wave were then
multiplied together, and the product of the numerator
probabilities was divided by that for the denominator
probabilities [20]. Probabilities for observed exposure
levels were calculated from logistic regression models
predicting insomnia at each time point (in SPSS v21; see
Additional file 1 for more details), Numerator probabil-
ities were estimated based on past exposure histories
only, while denominator probabilities were estimated
based on past exposure and covariate histories. Two sets
of analysis weights were produced, one with and one
without concurrent covariates included in the denomin-
ator model. Gender and social class were included in
both models, thus assuming that these are confounders,
rather than mediators of insomnia’s effect.
Including past exposure histories in the numerator
and denominator produces stabilised weights, which, in
comparison to simply taking the inverse of the probabil-
ity of exposure, helps to avoid excessive variability in the
weights [20]. We additionally tried truncating weights at
approximately their 5 and 95 percentiles to ensure that
results were not being overly driven by cases with ex-
treme weights [36], but this did not affect the findings.
Before employing the weights in MSMs we checked
whether the mean weight was close to one [36] and
whether they were balancing covariate histories across
those with and without insomnia. Balance in covariate
histories was assessed using standardised mean differences
in covariates at each time point after wave-specific weights
were applied (see Additional file 2 for details). Standar-
dised differences less than 0.1 were considered negligible
[37]. Initial assessment of covariate balance indicated
that some differences in past covariates remained after
weighting. This prompted some minor modification of
the weighting model until satisfactory balance was achieved
(e.g. adding some interactions to the denominator model;
see Additional file 1 for details).
Results
Table 1 shows descriptive statistics for the observed and
the imputed data, with imputed data also weighted for
attrition. Physical inactivity, poor diet and insomnia were
the most common risk factors across the five surveys.
Obesity and heavy drinking were the least common. Pro-
portions with particular characteristics in the weighted
and imputed data were similar to those in the observed
data, with slightly more insomnia, smoking, females and
manual households (suggesting respondents with these
characteristics were more likely to drop out or fail to
respond).
Next, we assessed the analysis weights. Means of the
analysis weights with and without concurrent covariates
were close to 1 at 1.026 and 1.007, respectively. Figure 2
shows standardised mean differences in covariates asso-
ciated with cumulative insomnia exposure (i.e. with each
additional wave where insomnia symptoms were re-
ported; associations with insomnia at each wave using
wave-specific weights are shown in Additional file 2).
These are presented for attrition weighting only, and for
the two sets of analysis weights with and without con-
current covariates included. Large mean differences in
Fig. 2 (>0.1) suggest substantial co-variation with cumu-
lative insomnia exposure. With attrition weighting only
(grey diamonds) this co-variation may represent a mix of
potential confounding and potential mediation (potential
because a confounding or mediating role also depends
on whether the covariate has a causal influence on type
2 diabetes). Thus, insomnia exposure shows substantial
co-variation with gender, social class, smoking, baseline
Table 1 Descriptive data
N = 996 Observed Imputed & Weighted
for Attrition
N % % missing N %
Person level (n = 996)
Female 541 54.3 0.0 553 55.5
Manual Occupation 303 30.7 0.9 338 33.9
Type 2 Diabetes at
wave 5
68 6.8 0.0 70 7.0
Repeated Measurement level (n = 4980)
Insomnia 1873 43.6 13.8 2246 45.1
Current Smoking 1496 32.6 7.9 1718 34.5
Physical Inactivity 2315 50.8 8.5 2575 51.7
Poor Diet 2564 57.3 10.2 2859 57.4
Obesity 865 19.3 9.9 946 19.0
Heavy Drinking 808 17.6 7.8 852 17.1
Psychiatric Distress 1033 27.3 23.9 1399 28.1
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heavy drinking, and especially psychiatric distress. There
was little co-variation with physical inactivity, obesity,
later measures of drinking, or diet (though later mea-
sures of diet approached the 0.1 threshold).
With the analysis weights the potential confounding
influences have been adjusted out, so any remaining co-
variation is viewed as potential mediation. Covariates
measured concurrently with insomnia could be potential
confounders or potential mediators of insomnia exposure
and the weights with and without these included respect-
ively reflect these different causal assumptions (both sets
of weights adjust for potential confounding from past
measures of covariates). Thus, adjusting for confound-
ing under the assumption that concurrent measures of
covariates are potential mediators (‘weighting with past
covariates only’; white squares in Fig. 2), removes co-
variation with gender, occupational class and smoking,
but not with baseline drinking or with psychiatric distress
(though co-variation with psychiatric distress is attenu-
ated). Adjusting for confounding under the more conser-
vative assumption that concurrent measures of covariates
are potential confounders (‘weighting with past and con-
current covariates’; black triangles in Fig. 2), removes asso-
ciations with most covariates, though there is still a little
co-variation with psychiatric distress, representing poten-
tial mediation (the association between cumulative insom-
nia exposure and GHQ at wave 3 is still >0.1).
Table 2 shows ORs, 95% CIs, and p-values for the
association between cumulative insomnia exposure and
type 2 diabetes incidence, as estimated with various
methods. The basic association, weighted only for attri-
tion, was that each additional wave of insomnia exposure
was associated with increased risk for type 2 diabetes. A
traditional regression model, conditioned on all the co-
variates, also showed this association (if anything it was
stronger in the conditioned regression model). The asso-
ciation was attenuated but remained borderline signifi-
cant in a MSM weighted for past covariates only, and all
but disappeared in a MSM weighted for both past and
concurrent covariates. In a sensitivity analysis with a less
conservative threshold for diabetes (HbA1c ≥ 6%), there
was only a borderline association in models weighted
for attrition only, and this was substantially attenuated
in MSMs weighted for covariates (past only or with
concurrent).
Discussion
Insomnia symptoms were investigated as a cause of
type 2 diabetes incidence in a community-based sample
of non-diabetic adults followed from approximately 36
to 57 years of age. MSMs were used to adjust for time-
varying confounding. While other studies have shown
associations with type 2 diabetes for shorter-term mea-
sures of insomnia [1, 2], this paper shows that risk for
type 2 diabetes increases as exposure to insomnia
symptoms accumulates over many years. However, as-
sociation between insomnia symptoms and type 2 dia-
betes appeared largely confounded by other factors.
Insomnia symptoms were also associated with being fe-
male, being in a manual class, smoking, heavy drinking
and especially with psychiatric distress. The findings
were sensitive to assumptions about the direction of
causation between concurrent measures of insomnia
Fig. 2 Standardised mean differences in covariates associated with cumulative insomnia exposure across 25 imputed data-sets
Table 2 Estimates of association between insomnia exposure
and type 2 diabetes incidence
Association between type 2
diabetes and cumulative
insomnia exposurea
Model OR 95% CI p-value
Attrition weighting only 1.26 1.03-1.54 0.028
Traditional logistic regressionb 1.34 1.06-1.70 0.015
MSM weighted on past covariates only 1.20 0.98-1.46 0.079
MSM weighted based on past and
concurrent covariates
1.08 0.85-1.37 0.554
aResults are weighted for attrition and averaged across 25 imputed datasets.
Cumulative insomnia exposure is a count of study waves where insomnia
symptoms were reported
bConditioned on gender, baseline occupational class and smoking, physical
inactivity, poor diet, obesity, heavy drinking, and psychiatric distress at
each wave
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symptoms and psychiatric distress (and to a lesser
extent perhaps heavy drinking). Where concurrent
measures of psychiatric distress were seen as potential
mediators of insomnia effects, there was still a border-
line association between insomnia symptoms and type
2 diabetes, which could represent a causal relationship,
assuming no further unmeasured confounding. How-
ever, if concurrent measures of psychiatric distress were
viewed as confounding insomnia effects, then the asso-
ciation with type 2 diabetes disappeared, suggesting a
non-causal association.
The findings under the more conservative assumption
of concurrent confounding contrast with small scale
experimental studies where restricted sleep stimulates
physiological changes similar to those in the development
of diabetes [38, 39]. Experimental sleep restrictions are
carefully controlled, short-term and may differ consider-
ably from the experiences of those who, in non-
experimental circumstances, report insomnia symptoms
over the long-term (which is what has been studied here).
Perhaps the physiological effects observed in short-term
experimental studies do not persist when sleep is curtailed
over the long-term. Alternatively, perhaps there is a
(weak) causal effect of long-term insomnia exposure, as-
suming mediation via psychiatric distress. In addition, a
study on the Penn State cohort showed highest risk for
type 2 diabetes when insomnia symptoms were combined
with short sleep duration [1]. Reporting insomnia symp-
toms does not necessarily equate with short sleep dur-
ation. Future studies might clarify whether long-term
experience of insomnia with short sleep duration has a
causal influence on type 2 diabetes.
The findings from MSMs also contrast with those from
a meta-analysis of observational studies using traditional
conditioned regression approaches [2]. MSMs have two
main advantages over traditional regression in that they
allow for mediated effects via time-varying covariates, and
avoid potential collider biases [20, 22]. Assuming covari-
ates increase risk for type 2 diabetes, allowing for medi-
ated effects might be expected to yield less conservative
effect estimates than with traditional regression, rather
than vice versa as observed here. That the MSM estimates
were more conservative therefore suggests the presence of
an unmeasured factor that confounds the association
between one of the covariates and type 2 diabetes, intro-
ducing collider bias when estimating effects of insomnia
(see Fig. 1b). This could be nothing more than prior
unmeasured histories of the time-varying confounders.
Non-collapsibility of ORs may also account for some
minor differences between conditioned and marginal
effect estimates [40], but this is unlikely to have been an
issue here as the outcome was rare.
In comparison to more traditional approaches, marginal
structural models have been known to yield results closer
to those of randomised experiments [41], but can be
sensitive to mis-specification of the exposure model [36].
Hence, here we examined results using two sets of weights
from different versions of this model, and performed fur-
ther sensitivity analyses with different variable definitions.
The findings were robust across these variations (if any-
thing showing less evidence for a causal effect in some
analyses), as well as to truncation of the weights to avoid
extreme values dominating the analysis. However, the
estimates of insomnia’s effects here do assume a linear,
dose-response, relationship between insomnia exposure
and type 2 diabetes, independent of other variables. Future
studies might explore non-linearity of effects, or interac-
tions with other variables such as psychiatric distress. For
example, we modelled insomnia exposure as cumulative
with greatest risk for type 2 diabetes among those experi-
encing chronic insomnia over all five interviews. Future
work could examine whether effects of intermittent and
chronic patterns differ more than would be expected by
the differences in duration of exposure.
Effects estimated from marginal structural models, as
for traditional regression, only indicate causation (or
lack thereof ), with the important assumption of no fur-
ther unmeasured confounding [20]. Although adjust-
ment was made for time-varying confounding within
the 20-year period of study, some respondents may, for
example, have had chronic patterns of insomnia symp-
toms that extended prior to the baseline measures, and
any causal influence of earlier unmeasured insomnia
symptoms on baseline covariates will have been ad-
justed out. Additionally, due to blood samples (for
HbA1c) only being taken at the final wave of the study,
we used an objective measure of type 2 diabetes from
that final wave. Therefore, whilst we excluded those
with baseline diabetes, based on self-report data, it is
possible that early development of type 2 diabetes
within the period of study (diagnosed or not) might
have influenced the levels of time-varying exposures or
covariates.
Conclusions
Our findings were sensitive to method. Traditional logistic
regression showed an association between insomnia
symptoms and type 2 diabetes incidence which would be
quite large in magnitude if multiplied by long-term expos-
ure. However, this method may be subject to bias from
time-varying confounders. Marginal structural models,
which overcome these potential biases indicated consider-
able attenuation in the association, the extent of which
depended on assumptions about causal direction between
concurrently measured insomnia symptoms and covari-
ates, particularly psychiatric distress. The attenuated asso-
ciation under those methods least likely to introduce bias,
suggests that associations between insomnia symptoms
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and type 2 diabetes are largely confounded by other fac-
tors. Whilst this study is not the equivalent of a rando-
mised trial, such trials can be expensive and lengthy, and
it might be better to focus research resources on other po-
tential modifiable causes where there is stronger observa-
tional evidence for a causal link. Psychiatric distress might
be a good candidate for further investigation since it ap-
peared to be the strongest potential confounder of the as-
sociation between insomnia and type 2 diabetes incidence.
Indeed, in this regard, treatment for insomnia may still
have some value as this can help reduce psychiatric dis-
tress, and the strongest evidence here of insomnia being
causally related to type 2 diabetes was when concurrent
measures of psychiatric distress were viewed as mediators,
rather than confounders.
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technical details of the specific models used to calculate analysis weights.
(DOCX 17 kb)
Additional file 2: Appendix 2. Covariate balance. Includes 5
supplementary figures showing how wave-specific weights achieve covariate
balance on prior measures of covariates. (DOCX 164 kb)
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